Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection Colombia.
Detection Principle
ImmunoAssay-Antibody
Target
IgG IgA IgM
Testing Method Category
ELISA
Testing Method
INgezim COVID 19 DR test
Testing Method - Additional Info
investigation on seroreactivity by using a commercial SARSCoV-2 ELISA test in samples collected from groups from different individuals, including patients diagnosed to have Dengue, Zika,and Chikungunya virus infection, between 2015 and 2019, in the Caribbean Colombian region
Reported Performance
sensitivity: 90.1%
Sample Size
127 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements